Clinical utility of NT-proBNP levels in late heart transplantation patients

Clinica Chimica Acta

Volumn 411, Issue 3-4, 2010, Pages 161-166

  Avello, Noelia ^a   Prieto, Belén ^a   Molina, Beatriz D ^a   Rodriguez Lambert, Jose L ^a   Álvarez, Francisco V ^a,b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

Heart transplantation; Natriuretic peptides; Prognosis; Rejection

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACUTE GRAFT REJECTION; ADULT; AGE; AGED; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CHEMICAL ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SEX;

AGED; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSTOPERATIVE PERIOD; PROGNOSIS; TIME FACTORS;

CHICKEN ANEMIA VIRUS;

EID: 72549083749     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.10.021     Document Type: Article

References (30)

1. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
2. Taylor D.O., Edwards L.B., Aurora P., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report-2008. J Heart Lung Transplant 27 (2008) 943-956
3. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
4. Omland T., and de Lemos J.A. Amino-terminal pro-B-type natriuretic peptides in stable and unstable ischemic heart disease. Am J Cardiol 101 (2008) 61-66
5. Yu C.M., and Sanderson J.E. Plasma brain natriuretic peptide-an independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart Fail 1 (1999) 59-65
6. Januzzi J.L., van Kimmenada R., Lainchbury J., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27 (2006) 330-337
7. James S.K., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108 (2003) 275-281
8. Heeschen C., Hamm C.W., Mitrovic V., Lantelme N.H., and White H.D. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110 (2004) 3206-3212
9. Hervas I., Arnau M.A., Almenar L., et al. Ventricular natriuretic peptide (BNP) in heart transplantation: BNP correlation with endomyocardial biopsy, laboratory and hemodynamic measures. Lab Invest 84 (2004) 138-145
10. Hervas I., Almenar L., Perez-Pastor J.L., et al. Radioimmunometric assay of B-type natriuretic peptide (BNP) in heart transplantation: correlation between BNP determinations and biopsy grading of rejection. Nucl Med Commun 24 (2003) 925-931
11. Talha S., Di Marco P., Doutreleau S., Rouyer O., Piquard F., and Geny B. Does circulating BNP normalize after heart transplantation in patients with normal hemodynamic and right and left heart functions?. Clin Transplant 22 (2008) 542-548
12. Mehra M.R., Uber P.A., Walther D., et al. Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker. Circulation 114 (2006) I21-I26
13. Aranda Jr. J.M., and Hill J. Cardiac transplant vasculopathy. Chest 118 (2000) 1792-1800
14. Billinghan M.E., Carry N.R., and Hammond M.E. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung disease. Heart Rejection Study Group. J Heart Transplant 9 (1990) 587-593
15. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
16. Avello N., Molina B.D., Llorente E., Bernardo M.J., Prieto B., and Alvarez F.V. N-terminal pro-brain natriuretic peptide as a potential non-invasive marker of cardiac transplantation rejection. Ann Clin Biochem 44 (2007) 182-188
17. Ationu A., Sorensen K., Whitehead B., Singer D., Burch M., and Carter N.D. Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children-a three year follow up. Cardiovasc Res 27 (1993) 2135-2139
18. Park M.H., Scott R.L., Uber P.A., Harris B.C., Chambers R., and Mehra M.R. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Cardiol 90 (2002) 1326-1329
19. Ambrosi P., Oddoze C., Riberi A., et al. Usefulness of N-terminal-pro-brain natriuretic peptide levels in predicting survival in heart transplant recipients. Am J Cardiol 94 (2004) 1585-1587
20. Anwaruddin S., Lloyd-Jones D.M., Baggish A., et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47 (2006) 91-97
21. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
22. Meirovich Y.F., Veinot J.P., de Bold M.L., et al. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J Heart Lung Transplant 27 (2008) 31-37
23. Arnau-Vives M.A., Almenar L., Hervas I., et al. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant 23 (2004) 850-856
24. O'Neill J.O., McRae III A.T., Troughton R.W., et al. Brain natriuretic peptide levels do not correlate with acute cellular rejection in De Novo orthotopic heart transplant recipients. J Heart Lung Transplant 24 (2005) 416-420
25. Wu A.H., Johnson M.L., Aaronson K.D., Gordon D., Dyke D.B., and Koelling T.M. Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements. J Heart Lung Transplant 24 (2005) 52-57
26. Cuppoletti A., Roig E., Perez-Villa F., et al. Value of NT-proBNP determinations in the follow-up of heart transplantation. Transplant Proc 37 (2005) 4033-4035
27. Bruins S., Fokkema M.R., Romer J.W., et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 50 (2004) 2052-2058
28. Mehra M.R., Uber P.A., Potluri S., Ventura H.O., Scott R.L., and Park M.H. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol 94 (2004) 454-458
29. Martinez-Dolz L., Almenar L., Moro J., et al. Prognostic value of brain natriuretic peptide in heart transplant patients. J Heart Lung Transplant 26 (2007) 986-991
30. Arora S., Gullestad L., Wergeland R., et al. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation. Transplantation 83 (2007) 1308-1315